ALNY vs NIC · P/E 76, rev $1.29B vs P/E 16, rev $359.1M
Alnylam Pharmaceuticals Inc (ALNY) versus Nicolet Bankshares Inc. (NIC) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Nicolet Bankshares Inc. (NIC) is a banks - regional company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported NIC revenue for 2026-06-30 was $359.1M. Net income was $72.1M. NIC currently screens at market cap $1.98B and trailing P/E 15.8.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. NIC currently screens at market cap $1.98B and trailing P/E 15.8.
Not investment advice. Open the ALNY and NIC stock pages for the full models.
Not investment advice.